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Abstract: Heterozygous missense mutations in IHH result in Brachydactyly 
type A1 (BDA1; OMIM 112500), a condition characterized by the shortening of 
digits due to hypoplasia/aplasia of the middle phalanx. Indian Hedgehog 
signaling regulates the proliferation and differentiation of chondrocytes and is 
essential for endochondral bone formation. Analyses of activated IHH signaling 
in C3H10T1/2 cells showed that three BDA1-associated mutations (p.E95K, 
p.D100E and p.E131K) severely impaired the induction of targets such as Ptch1 
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and Gli1. However, this was not a complete loss of function, suggesting that 
these mutations may affect the interaction with the receptor PTCH1 or its 
partners, with an impact on the induction potency. From comparative microarray 
expression analyses and quantitative real-time PCR, we identified three 
additional targets, Sostdc1, Penk1 and Igfbp5, which were also severely affected. 
Penk1 and Igfbp5 were confirmed to be regulated by GLI1, while the induction 
of Sostdc1 by IHH is independent of GLI1. SOSTDC1 is a BMP antagonist, and 
altered BMP signaling is known to affect digit formation. The role of Penk1 and 
Igfbp5 in skeletogenesis is not known. However, we have shown that both Penk1 
and Igfbp5 are expressed in the interzone region of the developing joint of 
mouse digits, providing another link for a role for IHH signaling in the 
formation of the distal digits. 
 
Key words: Indian Hedgehog, Brachydactyly type A1, Microarray, EMSA 
 
INTRODUCTION 
 
The Hedgehog gene (Hh) was initially identified in Drosophila as a segment 
polarity gene [1]. In mammals, the Hedgehog family includes the Sonic (Shh), 
Indian (Ihh) and Desert (Dhh) hedgehog genes. They represent key signaling 
molecules that mediate fundamental developmental processes, controlling the 
growth, patterning and morphogenesis of many regions of the body plan. SHH 
has been implicated in establishing the early left-right axis [2, 3] and the anterior 
and posterior axis in the limbs [3], and in regulating ventral cell fates in the 
central nervous system [4]. DHH has roles in germ-cell proliferation towards the 
late stages of spermatogenesis, in sertoli cell signaling, and in peripheral nerve 
ensheathment [5]. IHH has key roles in chondrogenesis, regulating the 
proliferation and differentiation of chondrocytes [6]. 
So far, studies have suggested that the Hedgehog genes signal through a similar 
mechanism controlled by two transmembrane proteins, SMO and PTCH. 
Genetic and biochemical studies have shown that PTCH suppresses the 
constitutive activity of SMO, and that the binding of Hedgehog to PTCH 
relieves this suppression, allowing the activation of downstream targets such as 
Ptch1 and Gli1, through the Ci/GLI family of transcriptional effectors [7-9]. It is 
not known how SHH, IHH and DHH control distinct biological processes during 
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development. IHH has similar biological properties to those of SHH, including 
the ability to regulate the conserved target genes, such as Ptch1 and Gli1 [6-9]. 
Other activated genes include the bone morphogenetic proteins, such as Bmp2 
and the 5’ Hoxd gene cluster (Hoxd11, 12 and 13) [3, 10, 11]. 
IHH is best known for its role in endochondral ossification, where it has a direct 
role in regulating chondrocyte proliferation, and where, via parathyroid 
hormone-related protein (PTHrP), it regulates chondrocyte hypertrophy through 
a negative feedback mechanism [6, 12]. Ihh is initially expressed in the 
chondrocytes of the early cartilaginous skeletal elements. On maturation, its 
expression becomes progressively restricted to post-mitotic prehypertrophic 
chondrocytes [13]. Its importance in endochondral ossification is highlighted in 
Ihh-null mouse mutants (Ihh-/-), which exhibit a severe reduction in skeletal 
growth [14]. Recently, we and others have shown that heterozygous missense 
mutations in IHH are associated with Brachydactyly type A1 (BDA1), an 
autosomal dominant disorder characterized by shortened or missing middle 
phalanges [reviewed in 15 and 16].  
Interestingly, the first three mutations that we identified – c.G283A (p.E95K), 
c.G391A (p.D100E) and c.C300A (p.E131K) – cluster on conserved amino acids 
across known vertebrate and invertebrate Hedgehog proteins, suggesting that 
these amino acids are important for Hedgehog function. Furthermore, they lie in 
close proximity on the surface of a groove for a molecular structure of IHH 
modeled on the X-ray crystal coordinates of SHH [17]. We hypothesize that 
these mutations affect IHH signaling through impaired interaction with 
interacting partners such as patched (PTCH), dispatched (DISP) and Hedgehog 
interacting protein 1 (HIP1). This hypothesis is supported by structural and 
biophysical analyses of IHH and its associated human mutations that cause 
BDA1, showing impaired interaction with its partners, such as PTCH1, HIP1 
and CDO [18]. Furthermore, from the study of a mouse model for BDA1 
carrying the p.E95K mutation, it was shown that this mutation not only affected 
the IHH signaling capacity, but also its range, which may be regulated by its 
interaction with PTCH1 and HIP1; thus, the mutant IHH signals outside its 
normal range, disrupting distal digit formation [19]. 
We aimed to gain further mechanistic insights into the IHH mutations causing 
BDA1 by studying the downstream consequence of these mutations on the 
expression of genes regulated by HH signaling. Here, we present evidence that 
the Hedgehog signaling was impaired in the three IHH mutations studied. In  
a comparative microarray analysis of gene expression profiles for genes that are 
not up-regulated relative to wild type IHH, Sostdc1, Penk1 and Igfbp5 were 
identified as possible new IHH signaling targets that may contribute to the 
molecular mechanism for BDA1. We confirmed that Penk1 and Igfbp5 are 
expressed in the developing joints of the distal digits in the mouse, and are 
activated via the transcription factor, GLI1. 
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MATERIALS AND METHODS 
 
Expression and purification of recombinant IHH-N proteins 
A cDNA encoding the amino-terminal domain of human IHH (amino acid 
residues 28-202) was amplified from an adult liver cDNA library, and the 
p.E95K (M1), p.E131K (M2) and p.D100E (M3) mutations were introduced by 
PCR mutagenesis using the respective primers: 5’-CTTCAAGGACGAGA 
AGAACACAGGCG-3’; 5’-GCTGCGGGTGACCAAGGGCTGGGACG-3’, 
and 5’-CACAGGCGCCGAACGCCTCATGACCC-3’.  
The bolded and underlined nucleotides represent the single nucleotide 
substitution in each of the primers. The amplified regions were verified by DNA 
sequencing and cloned into the pGEX-2T expression vector (Amersham) as 
GST-fusion constructs with a thrombin cleavage site in between. IHH-N proteins 
were expressed in E. coli BL21 (DE3) and purified using a previously described 
method [20]. The purity and identity of the IHH-N proteins were assessed by 
SDS-PAGE and by western-blot analysis with an IHH antibody (SC-1782, 
SantaCruz).  
 
Induction of Hedgehog signaling in C3H10T1/2 cells using purified IHH-N 
proteins 
C3H10T1/2 cells (ATCC) were cultured in BME supplemented with 10% FBS, 
100 U/ml penicillin and 100 µg/ml streptomycin, at 37ºC in a humidified 
incubator containing 5% CO2. To assess the induction of Hedgehog signaling for 
the wild type (Wt) and mutant IHH-N proteins, C3H10T1/2 cells grown to 
confluence in 12-well plates were cultured for 5 days in the presence of IHH-N 
proteins at different concentrations as indicated in the Results section. All of the 
induction assays were performed in triplicate. 
 
Induction of Hedgehog signaling in transiently transfected C3H10T1/2 cells 
Full-length human IHH cDNA expression constructs were generated and cloned 
into the pCMV-TnT vector (Promega). The vectors used in these experiments 
included pCMV-Wt-IHH (Wt-IHH), pCMV-M1-IHH (p.E95K mutation), 
pCMV-M2-IHH (p.E131K mutation), pCMV-M3-IHH (p.D100E mutation), 
with the empty vector as a control.  
One day before the transfection, C3H10T1/2 cells were plated at a density of 
2x105/cm2 in 24-well plates and cultured in BME supplemented with 10% FBS 
in the absence of an antibiotic. This allowed the cells to reach 80-90% 
confluency before transfection with 0.7 µg of plasmid DNA per well using 
LipofectamineTM 2000 (Invitrogen) according to manufacturer protocol 
#11668. All of the transfection experiments were performed in triplicate. The 
expression of the IHH proteins was also verified by western-blot using an SHH 
antibody (SC-9024, Santa Cruz) that cross-reacts with IHH.  
A GLI1 induction assay was used to study specific downstream targets of GLI1 
in the transfected C3H10T1/2 cells. A plasmid vector, pCMV-Flag-mGli1 (a full-
length mouse Gli1 cDNA construct) was used to express GLI1 in C3H10T1/2 
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cells, and an empty pCMV-TnT vector was used as a control. The Flag-mGli1 
cDNA plasmid was donated by Dr. Alexandra L. Joyner (NYU Medical Center). 
 
Microarray analysis of IHH targets in C3H10T1/2 cells 
Total RNA was isolated from C3H10T1/2 cells using the Trizol reagent 
(Invitrogen). Biotin-labeled cRNA probes were generated from total RNA using 
the Enzo RNA Transcript Labeling Kit (Affymetrix), further purified using the 
RNeasy Mini Kit (Qiagen), and fragmented in a fragmentation buffer (40 mM 
Tris-acetate, pH 8.1, 100 mM potassium acetate, and 30 mM magnesium 
acetate). 20 µg of labelled-cRNA was applied to each array. The cRNA yield did 
not differ significantly between the different samples, and the quality of the 
RNA samples was initially verified by test-array hybridization.  
The array analysis was performed by the GeneTech Biotechnology Company 
Limited (Shanghai, China) using mouse GeneChips 430A (Affymetrix, Santa 
Clara, CA). The sample labelling, hybridizaiton and scanning procedures were 
as described in the Affymetrix GeneChip Expression Analysis Technical 
Manual.  
The data analysis was carried out on five chips, corresponding to the control  
(un-induced cells), and cells induced with the Wt, M1, M2 and M3 IHH-N 
proteins. The Mouse 430A chip contains 18,000 genes and each gene is 
represented by 11 pairs of oligoucleotide probes. Each probe pair is 25-mer in 
length and is either a perfect match or a single central mismatch. The 
hybridization intensities were expressed as an average difference (subtracting the 
intensity of the mismatch probes from the intensity of the perfect match probes). 
The average difference values from the mouse GeneChip analysis were exported 
into the Excel program and then converted to ratios of fold-expression over 
background; that is, the fold difference between un-induced C3H10T1/2 cells 
relative to cells induced with the Wt or mutant M1, M2 and M3 IHH-N proteins. 
The fold-expression ratios were sorted using Microssoft Excel. To identify the 
common genes that are similarly altered between the Wt and the mutant group, 
we only considered genes with changes in the fold-expression ratios > 1.6 in the 
mutant groups when compared to the Wt group. These genes were then selected 
for verification by quantitative real-time PCR.  
 
RNA preparation and quantitative real-time PCR 
Total RNA was isolated from C3H10T1/2 cells using Trizol reagent (Invitrogen) 
as described above, and oligo d(T)-primed cDNA was prepared from 1 µg RNA 
using the SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen). 
The targeted genes were amplified and quantified using SYBR Green I 
fluorescence in quantitative real-time PCR as previously described [21]. The 
primers for the quantitative real-time PCR of the respective genes are listed in 
Tab. 1. Three separate PCR reactions were performed for each sample on an 
ABI PRISM 7900 Detection System (Applied Biosystems). In brief, each 
reaction was performed in a total volume of 10 µl containing 10 ng of cDNA  
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(10 ng), 5 µl Taqman® Universal PCR Master Mix (Applied Biosystems), 500 nM 
of each primer and 0.2 × SYBR® Green I (Molecular Probe, Inc.). All of the 
gene signals were normalized to the Gapdh signal. 
 
Tab. 1. The primers for quantitative real-time PCR 
 
Gene Product lengt Primers (5’-3’) 
Gapdh 107 bp GAAACCTGCCAAGTATGATGACA GGTCCTCAGTGTAGCCCAAGA 
Ptc1 82 bp TCAGTTGACTAAACAGCGTCTGGTA GACCCAAGCGGTCAGGTAGAT 
Gli1 95 bp GGCTGTCGGAAGTCCTATTCAC CAACCTTCTTGCTCACACATGTAAG 
Pthrp 78 bp GGAGATCCACACAGCCGAAA TGGTTTTTGGTGTTGGGAGC 
Akp2 78 bp GCCTGGATCTCATCAGTATTTGG GTTCAGTGCGGTTCCAGACAT 
Col2a1 78 bp GAGCAGCAAGAGCAAGGAAAA TCGCCATAGCTGAAGTGGAA 
Sostdc1 89 bp AGTTTGCAGTGAAAGCCAGGC ACAGAATGCAGCATCAGGTGC 
Penk1 71 bp AATTTCCTGGCGTGCACACT TCCTTGCAGGTCTCCCAGAT 
Igfbp5 71 bp TGTGTGGACAAGTACGGAATGAA AAGGCGTGGCACTGAAAGTC 
 
The GenBank accession numbers of the genes above are listed sequentially as follows: BC083080, U46155, 
AB025922, BC058187, J02980, BC030913, AY255635, BC049766, L12477. 
 
Whole cell extracts containing GLI1 proteins 
Cell extracts containing GLI1 proteins (GLI1 cell extract) were prepared from 
CHO cells transfected with the pCMV-Flag-mGli1 plasmid, with untransfected 
cells as the control. Cell pellets were lysed in ice for 30 min using the Totex 
buffer (20 mM HEPES, pH 7.9, 350 mM NaCl, 1% NP-40, 20% Glycerol,  
0.5 mM EDTA, 0.1 mM EGTA, 1 mM MgCl2, 1 mM PMSF, 1 mM DTT) 
containing a complete protease inhibitor cocktail (Roche). Cell debris was 
removed by centrifugation at 12,000 x g, 4ºC for 20 min. The presence of the 
Flag-tagged GLI1 proteins in the Gli1 extract was confirmed by western-blot 
analysis using a Flag-M2 antibody (Stratagene). 
 
Electrophoresis mobility shift assay (EMSA) 
EMSA assays were carried out in a final volume of 20 µl containing 20 mM 
HEPES, pH 7.9, 2 mM MgCl2, 2 mM DTT, 0.5 mM EDTA, 10% Glycerol,  
0.5 mg/ml BSA and 0.05 mg/ml Poly dI-dC. Each reaction contains 1 µl (35 fmol) 
of 29-bp double-stranded 32P-labeled probes with approximately 6-10 µg GLI1 
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or control cell extracts, and when appropriate, 2 µl (1.75 pmol) of matched 
unlabelled competitor oligonucleotides, or control competitor oligonucleotides 
with mismatches in the GLI-binding site. The binding reaction was carried out at 
RT for 30 min, and the resultant products were analyzed by polyacrylamide gel 
electrophoresis and the radioactive bands visualized on Kodak MIN-R2000 
films. When performing super-shift, the proteins were pre-incubated with an 
appropriate antibody at RT for 1 h prior to the addition of the probe.  
 
In situ hybridizations 
An Igfbp5 probe (1174 bp) was generated by PCR amplication from cDNA 
prepared from C3H10T1/2 cells using the primers 5’-GCCTCTCGGGTCTGT-
CCCCT-3’ and 5’-TTACCCACCATCTGGGCCCT-3’, cloned into the pGEM-T 
vector (Promega), and verified by sequencing. The Penk1 probe (430 bp) was 
donated by Dr Sarah Herzog, Max-Planck-Institute of Experimental 
Endocrinology. The sense and antisense probes were labelled with DIG using 
standard protocols with SP6 or T7 polymerase (Roche). The Ihh-null 
heterozygous mutant mouse was donated by Dr Andrew P. McMahon [14]. For 
the whole mount in situ hybridization, the limbs from the mouse embryos at 
E13.5 and E14.5 were fixed at 4ºC in 4% paraformaldehyde overnight, and 
hybridization with the sense and antisense probes was performed as described 
previously [22]. Color development was done with BM purple AP substrate 
(Roche) at 4ºC overnight. 
 
RESULTS 
 
Establishing a cell-culture system for the analysis of IHH signaling  
C3H10T1/2 is a well-established reporter cell line for Hedgehog signaling for 
SHH-N [23] and IHH-N proteins [24, 25], with the signal transduced through the 
PTCH/SMO/GLI pathway. We tested C3H10T1/2 cells for suitability as an 
assay system for detecting differences in response to Wt and mutant IHHs. 
C3H10T1/2 cells were transfected with an expression vector for the full-length 
Wt IHH cDNA. The induction of the known target genes Ptch1 and Gli1 was 
measured by quantitative real-time PCR over a period of 5 days. As expected, 
both of these targets were activated within the first day after transfection, and 
were maintained over the 5-day period with the maximum on day 2 (Fig. 1). On 
day 2, Ptch1 and Gli1 had been respectively induced by 15- and 58-fold in  
Wt IHH transfected cells relative to control cells transfected with an empty 
vector. However, an indirect target of IHH, Pthrp, had not been induced. On the 
other hand, Col2a1, a marker for chondrogenesis, had been slightly induced 
relative to the control, also with a maximal level of 3-fold on day 2 (Fig. 1). 
Alkaline phosphatase 2 (Akp2), a marker for osteogenesis, was induced from day 2, 
and reached a maximal level of 9-fold on day 4 (Fig. 1). 
The differentiation progression of C3H10T1/2 cells to osteoblasts upon 
Hedgehog signaling is well documented [23, 24], and can be used as an indicator 
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of Hedgehog signals. From this analysis, it appears that day 5 may be most 
informative for the measurement of the transcription activation of Ptch1 and 
Gli1, as well as the progression to osteogenesis based on Akp2 gene expression.  
 
 
 
Fig. 1. The optimal in vitro conditions for the analysis of IHH signaling in C3H10T1/2 
cells.  C3H10T1/2 cells were cultured over a period of 5 days transfected with full-length  
Wt IHH cDNA in 24-well plates. Total RNA was extracted from cells  harvested daily, and 
the relative expression levels of the indicated genes were assessed by quantitative real-time 
PCR. The expression levels of all of the genes tested were normalized to the Gapdh 
mRNA level in each sample. The relative mRNA expression (y-axis) represents the fold 
change for the expression of the genes relative to control cells that were not supplemented 
with Wt IHH-N. Each data point represents the mean with the standard deviation of tree 
separate experiments, each performed in triplicate.  
 
Hedgehog signaling was severely impaired for IHHs with BDA1 mutations 
As expression levels in transfected cells are difficult to control precisely, we 
performed a quantitative induction analysis of Ptch1, Gli1 and Akp2 using 
purified IHH-N (the N-terminal functional portion of Hedgehog proteins). We 
tested various concentrations of the Wt IHH-N protein at concentrations from  
0 to 1000 nM, and found that 500 nM to 750 nM was the optimal concentration 
range on day 5 of induction (data not shown). We compared the induction 
activity of the three BDA1 mutant IHH-N proteins, p.E95K (M1), p.E131K 
(M2) and p.D100E (M3), with Wt IHH-N at 500 nM in C3H10T1/2 cells.  
Wt IHH-N induced expression of Ptch1, Gli1 and Akp2, when compared with 
the uninduced control cells (Fig. 2A). By contrast, none of the mutant IHH-N 
(M1, M2 and M3) proteins induced Ptch1 expression to any significant level, 
while Gli1 was mildly induced, but to levels significantly lower than those 
induced by Wt IHH-N (Fig. 2A). The Akp2 expression remained at basal levels 
for all of the mutant IHH-N proteins, compared to a 2.4-fold increase for  
Wt IHH-N (Fig. 2A). Furthermore, the Wt and mutant IHH-N proteins were 
stable throughout the 5 days of the incubation period (data not shown), 
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indicating that the observed impaired activation of Hedgehog signals for the 
mutant IHH-N proteins was not due to a preferential degradation. 
 
 
 
Fig. 2. The relative potency of Wt and mutant IHH-N signaling in C3H10T1/2 cells.  
C3H10T1/2 cells were cultured for 5 days in 12-well plates supplemented with 500 nM 
(A) or 750 nM (B) of Wt and mutant (M1, M2 and M3) IHH-N proteins. At the end of the  
5-day period, the total RNA was extracted from the cells, and the relative expression levels 
of the genes indicated were assessed by quantitative real-time PCR. Bars with an asterisk 
indicate genes with a statistically significant induction level relative to the control cells, 
with p < 0.015. In all of the experiments, the normalization and standard deviation 
calculations were performed as described in Fig. 1. Wt: wild type, M1: p.E95K mutation, 
M2: p.E131K mutation, and M3: p.D100E mutation. 
 
An additional induction experiment with Wt IHH-N showed that the optimal 
induction concentration was closer to 750 nM. Therefore, we repeated the 
Hedgehog signaling induction comparison between the Wt and mutant IHH-N 
proteins at 750 nM, and also included an induction expression analysis of 
Col2a1 and Pthrp. A similar pattern of induction to the 500 nM concentration 
was obtained for Ptch1, Gli1 and Akp2 (Fig. 2B), again with a significant 
induction impairment for the mutant IHH-N proteins compared with the Wt. 
Consistent with the cell transfection study (Fig. 1), neither Col2a1 nor Pthrp 
were induced by the mutant and Wt IHH-N proteins (Fig. 2B). Interestingly, 
while the induction of Gli1 was relatively higher at 750 nM (9-fold) compared to 
500 nM (2.5-fold) for the Wt IHH-N, the induction of Ptch1 remained similar 
(2-fold), indicating that the level of Gli1 induction by IHH is more sensitive to 
the HH concentration than Ptch1. Like Gli1, the induction of Akp2 was similarly 
elevated to 5-fold at 750 nM compared to 2.5-fold at 500 nM for the Wt IHH-N. 
The Akp2 expression remained at basal levels for all of the mutant IHH-N 
proteins.  
Mature Hedgehog proteins are modified by two lipid groups, an N-linked 
palmitate at the amino terminus, and a covalently bound cholesterol at the  
C-terminus [25]. These modifications are not present when the IHH-N proteins 
are expressed and purified from E. coli, but can significantly enhance in vitro 
Hedgehog signaling [26]. Therefore, we performed transfection expressions in 
the C3H10T1/2 cells with Wt and mutant full-length cDNA constructs for  
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a comparison of Ptch1 and Gli1 induction. IHH expressed in a mammalian cell 
system would be fully processed and modified, allowing optimal activity. 
Although semi-quantitative, the expression level and presumably the transfection 
efficiency were similar for the Wt and mutant constructs when the IHH protein 
level from the cell extracts was assessed by western-blot analysis (Fig. 3A).  
 
 
 
Fig. 3. The relative potency of Wt and mutant IHH cDNA signaling in C3H10T1/2 cells. 
C3H10T1/2 cells were transfected with a control vector or vectors carrying Wt or mutant 
IHH cDNA. A – IHH protein expression from the cell extract was verified by western-blot 
analysis. The precursor form of IHH is around 46 kDa and the active form is around  
20 kDa, as indicated by the arrows. B – The total RNA was extracted 24  after transfection, 
and the relative expression levels of the genes indicated were assessed by quantitative real-
time PCR. The control represents cells transfected with an empty vector. In all of the 
experiments, the normalization and standard deviation calculations were performed as 
described in Fig. 1. 
 
Given that 2 days following the transfection was the optimal induction period for 
the Wt IHH (Fig. 1), we performed a quantitative real-time PCR analysis of 
Ptch1 and Gli1 induction comparing the cells’ transfected Wt and mutant IHH 
cDNA constructs 2 days after transfection. Consistent with the use of purified 
IHH proteins, the inductions of Ptch1 and Gli1 were significantly impaired for 
cells transfected with the mutant constructs, with a reduction of almost 70% 
compared to the Wt for Gli1, and one of 80% for Ptch1 (Fig. 3B). The difference 
in the Akp2 expression between the Wt and mutant IHH-N was reflected in  
a reduced enzymatic activity, confirmed using an alkaline phosphatase staining 
assay of the C3H10T1/2 cells after 5 days of induction (data not shown). 
Together, the cell transfection and protein induction data suggested that the 
mutations p.E95K, p.E131K and p.D100E in IHH impaired the transduction of 
Hedgehog signals, but did not cause a complete loss of function. While the  
in vitro conditions used here may not be a true reflection of the physiological 
concentrations, the data nevertheless supports a significant difference between 
the Wt and mutant IHH proteins and is consistent with the recent reports on the 
impact of such mutations [18, 19].    
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Identification of genes that were differentially induced in Wt and mutant 
IHH signaling 
The differential induction of the Hedgehog target genes (Ptch1 and Gli1) 
between the Wt and mutant IHH proteins offered an opportunity to perform  
a comparison of gene expression profiles to identify additional Hedgehog targets 
that may be similarly affected. A comparative microarray expression analysis 
was performed using the Mouse 430A chip from Affymetrix for RNAs extracted 
from C3H10T1/2 cells transduced for 5 days with 750 nM of Wt and mutant 
IHH-N proteins and for RNAs from uninduced cells. 
Tab. 2 summarizes the number of genes identified in each array and the 
differences in the comparative analysis. To identify the genes that are affected, 
we focused on the genes that are at least 1.6-fold down-regulated in the mutant 
IHH-N-induced cells relative to Wt. We then selected the genes in this list that 
are common in all the three mutant IHH-N-transduced cells. Five genes survived 
this filter: Ptch1, Sostdc1, Igfbp5, Penk1 and Rbbp4. The inclusion of Ptch1 in 
this small list of genes suggested that the filtering process is reasonable, and 
sufficiently stringent to identify known targets. Surprisingly, Gli1 was not 
included in this list. On closer inspection, it appeared that Gli1 was not well 
detected in the Wt and mutant IHH-N inductions, which may be ascribed to  
a low probe specificity and efficiency for this gene in the Affymatrix Mouse 
430A chip.  
 
Tab. 2. A summary of the gene numbers in the comparative gene expression profiling  
 
Arraya No. of genes determined to be expressedb Comparisons 
No. of genes with an 
increase ≥ 1.6-foldc 
No. of genes with a 
decrease ≥ 1.6-foldc 
C 9919    
Wt 11263 Wt vs C 175 44 
M1 10442 Wt vs M1 94 78 
M2 11231 Wt vs M2 102 74 
M3 11420 Wt vs M3 180 213 
 
aArray hybridized with cRNA synthesized from total RNA extracted from the control (C) or 750 nM protein 
induction (Wt or mutant IHH-N , M1, M2 and M3). bIf a gene transcript is determined to be expressed in the array, 
the detection scaling will be expressed as “Present” in the original data. cFold changes of expression levels are 
expressed as the log2 ratio in the original data. A log2 ratio of 1 is the same as a Fold Change of 2. 
 
Of the four genes that were identified as potential new targets of IHH signaling, 
only three, Sostdc1, Igfbp5 and Penk1, were confirmed to be up-regulated in  
Wt IHH-N induction by quantitative real-time PCR (Fig. 4A). Among them, 
Sostdc1, encoding a secreted BMP antagonist [27], reached the highest induction 
level of 20-fold for the Wt proteins (Fig. 4A). We were unable to confirm any 
induction for Rbbp4 (data not shown). However, the potential new IHH targets 
Sostdc1, Igfbp5 and Penk1 were not induced to any significant level by the 
mutant IHH-N proteins (Fig. 4A).  
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Fig. 4. Quantitative real-time PCR assessment of additional targets of IHH.  
A – C3H10T1/2 cells were cultured in 12-well plates for 5 days supplemented with 750 nM 
of Wt and mutant (M1, M2 and M3) IHH-N proteins. At the end of the 5-day period, the 
total RNA was extracted from the cells, and the relative expression levels of the new target 
genes Sostdc1, Igfbp5 and Penk1 were assessed by quantitative real-time PCR.  
B – C3H10T1/2 cells were transfected with a cDNA expression construct for the mouse 
Gli1 gene. The total RNA was extracted 24  after transfection, and the relative expression 
levels of the genes indicated were assessed by quantitative real-time PCR. Genes with an 
asterisk indicate a statistically significant induction (p < 0.020) following Gli1 transfection 
relative to the control cells transfected with an empty vector. The normalization and 
standard deviation calculations were performed as described in Fig. 1. 
 
IHH signaling activates Penk1 and Igfbp5 via GLI1 
At present, the known Hedgehog target genes are transduced/regulated by the 
GLI family of transcription factors (GLI1, GLI2 and GLI3) via the conserved 
HH-PTCH-GLI pathway [28, 29]. Therefore, we performed a transfection 
induction in C3H10T1/2 cells with a full-length mouse Gli1 cDNA expression 
construct, and monitored the induction of Sostdc1, Penk1 and Igfbp5 by 
quantitative real-time PCR, with Ptch1 expression as an internal positive control. 
As expected, 24 h after transfection with the Gli1 cDNA construct, the mRNA 
level of Ptch1 was up-regulated by a factor of 2.2-fold relative to the control 
cells (Fig. 4B). The expression levels of Penk1 and Igfbp5 were also 
significantly up-regulated upon Gli1 transfection (Fig. 4B). Interestingly, the 
expression of Sostdc1 was not up-regulated, but rather down-regulated upon 
Gli1 transfection (Fig. 4B). 
GLI1 is a sequence-specific DNA-binding protein that interacts with the motifs 
GACCACCCA, and the direct binding of GLI1 to this 9-bp consensus sequence 
in the Ptch1 promoter was previously demonstrated in gel-shift assays [29, 30].  
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Fig. 5. Binding of GLI1 transcriptional factor to the promoter region of the newly revealed 
target genes. A – The sequences in the promoter regions of the mouse (M) and rat (R) 
Ptc1, Penk1 and Igfbp5 genes are sown with the putative GLI1-DNA binding motifs 
underlined. A base that differs from the conserved 9-bp consensus in the mouse Igfbp5 is 
indicated in bold and italic. B – CHO cells were transfected with a mouse Flag-Gli1 
expression construct, and the presence of the GLI1 protein in the whole cell extracts 
(GLI1) verified by western-blot analysis using a Flag® antibody. A specific band (arrow) 
with an apparent MW of 120 kDa was detected specifically in the Gli1-transfected cells 
compared to the control CHO cells (Con). The whole cell extract containing GLI1 was 
used as the source of GLI1 proteins for EMSA. C – EMSA demonstrating the binding of 
GLI1 to DNA fragments containing putative GLI1 binding motifs identified in Penk1 and 
Igfbp5 (panel A). The sequences of the 32P-labeled labelled probes are as indicated in panel 
A. The reagents present in each reaction are indicated with a plus sign (+). “GLI1” and 
“control proteins” respectively represent whole cell extracts from CHO cells transfected 
with a Gli1 expression vector or control CHO cells. The “competitor” is a 100-fold excess 
of unlabelled DNA probe, and the “mutant competitor” is a control competitor DNA with 
mismatches in the GLI-binding site (panel A). Products were analyzed by polyacrylamide 
gel electrophoresis and radioactive bands visualized on Kodak films. Super-sift was 
performed using a “Flag antibody” to the Flag-tagged GLI1 fusion protein. The arrow 
indicates the sifted bands. Lanes for the rat and mouse Penk1 probes are as indicated in 
lanes 1-11, and the rat and mouse Igfbp5 probes in lanes 12-21. 
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Given that the Gli1-transfection assay suggested Penk1 and Igfbp5 could be 
direct targets for GLI1, we evaluated these two genes in both the mouse and rat 
genomes, and identified the 9-bp consensus sequences in the core promoter 
regions of Penk1 and Igfbp5 (Fig. 5A). The putative 9-bp motifs are conserved 
in both mouse and rat Penk1 and Igfbp5, with the exception of a one-base 
change in the mouse Igfbp5 (Fig. 5A). 
To directly demonstrate an interaction between GLI1 and the 9-bp motif in the 
promoter region of Penk1 and Igfbp5, we performed electrophoretic mobility 
shift assays (EMSA) with GLI1 and DNA containing the consensus sequences in 
Penk1 and Igfbp5. The source of the GLI1 proteins was from whole cell extracts 
of CHO cells transfected with a Flag-tagged Gli1 cDNA expression construct. 
The presence of GLI1 proteins in the extract was confirmed by western-blot 
(Fig. 5B). The DNA fragments were generated from paired oligonucleotides 
representing a 29-bp region of the promoter containing the GLI1-binding motif 
(Fig. 5A). EMSA analysis clearly demonstrated the binding of GLI1 to DNA 
containing the 9-bp motif present in Penk1 with the appearance of mobility 
shifted bands in the presence of cell extracts containing GLI1 (Fig. 5C, lanes 5, 
7, 9 and 11). No mobility shifts were observed from the extract of the control 
CHO cells in the Penk1-GLI1 binding reactions (Fig. 5C, lanes 1 and 2). 
However, the Flag® antibody that would bind to the Flag-tagged GLI1 did not 
detect a supershift (Fig. 5C, lane 3). The reason for this is not clear, but it may 
be related to the binding of the GLI1 to the DNA masking the antibody epitope, 
or to the binding of the antibody to GLI1 interfering with its interaction with the 
DNA probe. Similar results were obtained for the binding of GLI1 to the motif 
in the promoter region of Igfbp5 (Fig. 5C, lanes 12-21). The binding to DNA of 
the rat Igfbp5 sequence was very strong (Fig. 5C, lanes 15 and 17) compared to 
the results for the mouse sequence (Fig. 5C, lanes 19 and 21). This may be the 
reason for the faint gel-shift band in the control reaction with cell extracts from 
the control CHO cells (Fig. 5C, lane 12). 
 
Penk1 and Igfbp5 are expressed at the interzone of a development joint in 
distal digit formation 
To correlate IHH signaling with the possible involvement of the new targets, 
Penk1 and Igfbp5, in the molecular consequence for BDA1, we performed 
whole-mount in situ hybridization to compare the expression pattern between Wt 
and Ihh-null (Ihh-/-) mutant mouse digits. In the Wt digits, Penk1 is expressed in 
the developing interzone, and Igfbp5 expression is detected in the developing 
interzone, interdigital and phalangeal regions at E13.5 and E14.5 (Fig. 6).  
In Ihh-/- mice, Penk1 expression is abolished in the developing digits, and the 
expression of Igfbp5, although maintained in the interdigital and phalangeal 
regions, was not distinctly observed in the presumptive interzone (Fig. 6). These 
results suggest that in part, the expression of these two genes, in particular 
Penk1, in the developing digital joints is under the regulation of Ihh signaling. 
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Fig. 6. The expression of Penk1 and Ifgbp5 in the mouse forelimb. A whole mount in situ 
hybridization of the forelimb sows the expression of Penk1 and Igfbp5 at E13.5 and E14.5. 
The white arrows indicate the position of the future phalangeal joint and the grey arrows 
indicate the position of phalangeal region.  
 
DISCUSSION 
 
Brachydactyly type A1 (BDA1) is part of the brachydactyly family of inherited 
disorders characterized by shortened phalanges or metacarpals. It was first 
identified by Farabee in 1903, and was the first recorded disorder of the 
autosomal dominant Mendelian trait in humans [31]. However, it was only 
recently that IHH was identified as a locus for BDA1 [17]. So far, heterozygous 
missense mutations in IHH have been identified in BDA1 patients [15, 16] and 
homozygous missense mutations in patients with Acrocapitofemoral Dysplasia [32].  
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The N-terminal fragment of Hedgehogs has all the known signaling activity, 
whereas the C-terminal fragment is responsible for the intracellular 
autoproteolytic processing during biosynthesis [33, 34]. Our assay of 
C3H10T1/2 cells for Ptch1 and Gli1 expression following induction with  
Wt IHH-N is consistent with the PTCH/SMO/GLI pathway. Here, we tested the 
signaling activities of the three IHH mutations (p.E95K, p.D100E and p.E131K) 
for BDA1 in cultured cells and demonstrated that these mutations do not result 
in a complete loss of function. However, the ability of the mutant IHHs to 
“fully” induce a Hedgehog response was significantly compromised when tested 
in C3H10T1/2 cells, suggesting similar outcomes in chondrocytes in vivo.  
The three studied missense mutations (p.E95K, p.D100E p.E131K) all resulted 
in reduced Hedgehog signaling as determined by the reduced activation of the 
target genes Ptch1 and Gli1. At the optimal induction concentration of 750 nM 
for unmodified Wt IHH-N proteins, Gli1 induction was reduced by up to 80% 
for the mutant IHH-N proteins compared to the Wt, and no induction of Ptch1 
was detected from the mutant IHH-N proteins. It is not clear why there is  
a differential reduction between these two target genes. At this concentration, it 
is likely that for the Wt IHH-N proteins, the PTCH1 on the surface of the 
C3H10T1/2 cells is fully saturated with the HH proteins, while for the mutant 
IHH-N proteins, it is possible that there are still unbound PTCH1 receptors, and 
it is thus not possible to activate the signaling cascade to a level sufficient for 
Ptch1 expression. This may be related to the proposed ratiomatric (the ratio 
between HH-bound and unbound PTCH1) activation of target genes [35]. 
The mechanism of how the missense mutations affect Hedgehog signaling is not 
fully understood. Given that they can transactivate some targets, albeit to  
a reduced level, they are not complete loss-of-function mutations, and some 
interaction with the receptor PTCH1 does occur. It is possible that the binding 
efficiency could be significantly affected. Because HH proteins can function 
across species, and vertebrate HH proteins activate a common pathway [6-9, 37], 
it is likely that the surface residues important for inductive activity and 
ligand/receptor interaction could be conserved. Indeed, the IHH mutations 
studied here are on conserved residues that could be involved in the binding with 
PTCH1 [17]. Although they are not at the exact position when aligned with the 
IHH-N protein sequence, similar engineered mutations (p.E90A, p.D132A and 
p.E138A) in the SHH-N proteins resulted in reduced binding coefficients for 
PTCH1 [36]. More recently, the p.E95K, p.D100E and p.E131K mutations were 
mapped on an X-ray crystal structure of SHH within a calcium binding site,  
a hotspot for mediating interactions with PTCH1, HIP1, CDO and GAS1 [18]. 
Furthermore, the p.D100E and p.E131K mutations were shown to affect IHH 
interaction with PTCH1 and HIP1 in a cell-based binding assay [18], and the 
effect of the p.E95K mutation was shown in a mouse model for BDA1, affecting 
binding to PTCH1 and HIP1, altering the capacity and range of signaling [19].  
It is also possible that these mutations alter the interaction with the recently 
discovered PTCH1 binding partners, the Ihog surface proteins, CDO and BOC 
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[38-40], or the interaction with the cell surface HSPG such as glypican [41]. 
IHOGs and glypican cooperatively assist the binding of HH proteins to PTCH. 
This is important to fully activate the HH signaling. Interestingly, CDO is not 
expressed in C3H10T1/2 cells [42], so the observed reduced signaling potency is 
unlikely to be due to an altered interaction with CDO. The expressions of BOC 
in the C3H10T1/2 cells and CDO and BOC in the chondrocytes have yet to be 
determined, and would be important to test in the future to fully understand the 
molecular consequence of these mutations in IHH signaling.  
Given that mice heterozygous for an Ihh-null allele have a normal skeletal and 
no observable digit abnormalities [19], and that IHH heterozygous mutations 
resulted in an abnormal digital phenotype in humans, the molecular mechanism 
for BDA1 is unlikely to be a simple reduction in the signaling potency of the 
mutant IHH proteins. Indeed, in the study of the mouse model for BDA1 [19], it 
was shown that a reduced signaling capacity may be responsible for a reduced 
growth of the long bones, and thus the associated short stature; however, there 
was also an extended range of signaling in the developing digits that may be the 
primary reason for the brachydactyly phenotype. While altered interaction with 
PTCH1 and HIP1 could in part explain the increased signaling range [19], it is 
possible that the BDA1 mutations could affect the formation of the multimeric 
complex, or interaction with HSPG, altering its diffusion through the matrix and 
thus the effective concentration gradient for short- and long-range signaling [26]. 
Furthermore, only limited targets of IHH signaling have been identified. Thus, to 
fully understand the molecular basis of the mutations and the consequences of an 
abnormal IHH signaling, it would be important to study additional genes that are 
altered as a consequence of the mutations. 
To better understand the cascade of molecular signals that may be affected, we 
performed a microarray analysis by comparing the gene expression profiles from 
the activation of IHH signaling in the C3H10T1/2 cells. In the IHH activation of 
the mutant proteins, there were many genes that were either up- or down-
regulated compared with the Wt (Tab. 2). Given that all three mutations result in 
BDA1, we considered the expression profiles of the three mutant proteins as 
biological replicates, and focused on the common genes that are down-regulated 
in all three mutant protein-activated cell lines, comparing them to the genes 
activated with the Wt IHH-N proteins.  
There were five genes that satisfied these selection criteria, including the known 
target Ptch1. Of the four potential new targets, we confirmed the change in 
expression level for three genes, Sostdc1, Penk1 and Igfbp5, via quantitative 
real-time PCR, with Sostdc1 induced to the greatest extent upon IHH activation. 
These new targets were not significantly activated by the mutant IHH-N 
proteins. Penk1 and Igfbp5 were shown to be potentially regulated by GLI1, and 
their non-activation by the mutant IHH-N proteins is consistent with our 
observation that Gli1 induction was impaired in mutant IHH-N-induced cells. 
The conserved 9-bp GLI1 binding motifs are present in the promoter regions of 
Penk1 and Igfbp5, but absent in Sostdc1. Thus, Sostdc1 appeared to be not 
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regulated through GLI1 from our finding, but is strongly up-regulated upon IHH 
signaling. Its expression has been implicated to be regulated by BMPs such as 
BMP2 and BMP7 [27].  
The relationship between IHH and SOSTDC1 has not been previously 
demonstrated. However, SHH induction of digit elongation/extra phalanges is 
thought to be mediated by BMPs [43], linking HH and BMP signaling. Given 
that SOSTDC1 is a BMP antagonist [27], perhaps the regulation of BMP 
signaling by HH is via Sostdc1 expression. Previous studies have shown that 
other BMP antagonists, such as NOGGIN and CHORDIN, are also up-regulated 
after Ihh misexpression in chicken [10], further substantiating a relationship 
between IHH and BMP signaling in skeletogenesis [44, 45].   
Currently, several genes relating to brachydactylies have been identified, and 
these genes are related to BMP/TGFβ signaling. Mutations in BMPR1B, the 
high-affinity receptor for GDF5, cause brachydactyly type A2 (BDA2; OMIM 
112600), a condition characterized by a shortening of the index finger due to 
hypoplasia/aplasia of the middle phalanx [46]. Overexpression of the mutant 
BMPR1B in the chick embryo resulted in a brachydactyly phenotype similar to 
that in humans; it acted in a dominant-negative manner [46]. Mutations in the 
human GDF5 gene result in skeletal malformation syndromes including 
brachydactyly type C (BDC; OMIM 113100) [47]. The majority of mutations in 
GDF5 described so far are nonsense and frame shift mutations that presumably 
result in a loss of function [48]. However, a recent study reported an R438L 
mutation in GDF5 that did not alter binding to BMPR1B but increased binding 
to BMPR1A, the receptor normally activated by BMP2, and this mutation 
resulted in the BDA2 phenotype [48]. Thus, altered BMP signaling as a result of 
impaired SOSTDC1 expression due to abnormal IHH signaling for BDA1 is  
a possibility that needs to be tested.  
The correlation of PENK1 and IGFBP5 to brachydactylies is less obvious. 
Insulin-like growth factor I (IGF-I) is expressed in the chondrocytes and has an 
essential role in endochondral ossification [49]. IGFBP5 is a member of a family 
of six high-affinity IGF-binding proteins that orchestrate IGF action, and is the 
most conserved of the IGFBPs between species [50]. Abnormal Igfbp5 
expression in mice results in whole-body growth inhibition and retarded muscle 
development [50]. A role in in vitro chondrogenesis has also been suggested 
[51], and Igfbp5 was demonstrated to be regulated by SHH in early chicken 
embryogenesis [52]. Igfbp5 is also found at higher levels in regions of cell death 
in the mouse mutant Hypodactyly, implying a role in limb bud development 
[53]. Our observed expression of Igfbp5 in the mouse interdigital and phalangeal 
regions at E13.5 and E14.5 is consistent with a previous report [53]. However, 
we also showed expression in the interzone of the developing digit joints using 
two independent probes that we generated. This slight variation in the expression 
pattern may be related to the use of a mouse cDNA probe in the current study 
and a rat probe in the previous study [53].  
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Penk1 was first reported to modulate responses to painful stimuli [54]. At 
present, there is no information suggesting a link for Penk1 to skeletogenesis. Its 
expression together with the Igfbp5 in the Gdf5 expression domain [55] of the 
developing joints is the first indication. In the Ihh-null mice, the lack of 
expression of these two genes in the developing digital joints further supports  
a link between IHH signaling and joint formation. However, it is possible that in 
the Ihh-null mice, the lack of Penk1 expression in the presumptive joint regions 
is related to a developmental abnormality where the joints are not formed or 
delayed.   
The roles of Penk1 and Igfbp5 in distal digit formation and how they may 
regulate joint development within the signaling network of IHH remains to be 
determined. Characterization of the potential digit and joint abnormalities in 
mouse mutants for these two genes, and studies of the genetic interactions with 
the BDA1 mouse [19] would provide further insights into the interactive 
network of genes and the brachydactyly phenotype.  
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